Ceftriaxone & Sulbactam Injection IP - ERCEFT SB 375 Injection

ERCEFT SB 375 Injection
Composition:- Ceftriaxone 250mg + Sulbactam 125mg

ERCEFT SB 375 Injection – Ceftriaxone & Sulbactam Injection IP combines Ceftriaxone, a powerful third-generation cephalosporin, with Sulbactam, a beta-lactamase inhibitor, to deliver broad-spectrum protection against difficult-to-treat pathogens. The synergy between the two ensures reliable efficacy against resistant strains, including ESBL-producing E. coli and Klebsiella. Administered via IV or IM, it achieves excellent systemic distribution and tissue penetration for rapid infection control.

Key Points of Ceftriaxone & Sulbactam Injection IP – ERCEFT SB 375 Injection
• Broad & Potent Coverage – Combines bactericidal activity of Ceftriaxone with sulbactam’s beta-lactamase inhibition for enhanced activity against resistant organisms.
• Reliable in Severe Infections – Effective for complicated infections caused by gram-negative, gram-positive, and anaerobic bacteria.
• Synergistic Dual Action – Ceftriaxone blocks bacterial cell wall synthesis, while sulbactam restores drug sensitivity, ensuring comprehensive antibacterial action.

Can be Prescribed by:
• Pulmonologists
• Urologists
• Dermatologists
• Gastroenterologists
• Orthopedicians
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.